Ilze Upeniece
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ilze Upeniece has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alise Balcere
Department of Dermatology and Venereology, Riga Stradiņš University, LV-1010 Riga, Latvia
1 shared publication - Angelina Konovalova
Riga Stradins University, Riga, Latvia
1 shared publication - Arnolds Jezupovs
Clinic of Surgical Infections, Riga East University Hospital, Riga, Latvia; Faculty of Medicine, University of Latvia, Riga, Latvia
1 shared publication Ilona Hartmane
Riga Stradins University, Riga, Latvia
1 shared publicationIngmārs Mikažāns
Riga Stradins University, Riga, Latvia
1 shared publicationKaspars Snipe
Department of Surgery Riga 1st Hospital Riga Latvia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1) , 2117348
A Questionnaire Survey Study in one Clinical Center: Skin Emollient–Use Patterns Among Patients With Atopic Dermatitis of Varying Severity
Introduction: Atopic dermatitis (AD) significantly burdens the quality of life of patients and their families. This study assesses the proportion of patients with AD who followed the European Academy of Dermatology and Venereology (EADV) guidelines for emollient use and examines its correlation with disease severity assessed using the Patient‐Oriented Eczema Measure (POEM). Methods: A questionnaire‐based survey was conducted among patients of Riga First Hospital with AD diagnosis. The questionnaire included the POEM score and items assessing emollient‐use behaviors. The analysis was performed using IBM SPSS version 29. Results: Among 92 patients with AD, reported adherence to emollient‐use guidelines was low: 37% applied emollients ≥ 2 times/day, 31.5% applied whole body, 28.3% used them daily regardless of symptoms, and only 23.9% used adequate volumes (≥ 200 mL/week). Patients with severe AD were more likely to apply emollients ≥ 2 times/day ( p = 0.004) and daily, regardless of symptoms ( p = 0.005). A greater proportion of adults reported applying emollients ≥ 2 times/day (48.1% vs. 15.5%, p = 0.001). Overall, 42% reported adverse reactions, most commonly burning or irritation. Conclusions: Emollient use remains suboptimal. These findings highlight the need for improved adherence support, better product tolerability, and consideration of economic factors in AD management.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1) , 2117348
Open AccessA Questionnaire Survey Study in one Clinical Center: Skin Emollient–Use Patterns Among Patients With Atopic Dermatitis of Varying Severity
Introduction: Atopic dermatitis (AD) significantly burdens the quality of life of patients and their families. This study assesses the proportion of patients with AD who followed the European Academy of Dermatology and Venereology (EADV) guidelines for emollient use and examines its correlation with disease severity assessed using the Patient‐Oriented Eczema Measure (POEM). Methods: A questionnaire‐based survey was conducted among patients of Riga First Hospital with AD diagnosis. The questionnaire included the POEM score and items assessing emollient‐use behaviors. The analysis was performed using IBM SPSS version 29. Results: Among 92 patients with AD, reported adherence to emollient‐use guidelines was low: 37% applied emollients ≥ 2 times/day, 31.5% applied whole body, 28.3% used them daily regardless of symptoms, and only 23.9% used adequate volumes (≥ 200 mL/week). Patients with severe AD were more likely to apply emollients ≥ 2 times/day ( p = 0.004) and daily, regardless of symptoms ( p = 0.005). A greater proportion of adults reported applying emollients ≥ 2 times/day (48.1% vs. 15.5%, p = 0.001). Overall, 42% reported adverse reactions, most commonly burning or irritation. Conclusions: Emollient use remains suboptimal. These findings highlight the need for improved adherence support, better product tolerability, and consideration of economic factors in AD management.
- Open Access
- 16 October 2023
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 15 (1) , 182-189
Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
This case report discusses immunoglobulin-induced erythema multiforme (EM), a rare and understudied condition that requires further investigation. The report presents the case of a 69-year-old woman with a history of chronic lymphocytic leukemia who developed an acute hypersensitivity reaction to intravenous gamma globulin medication. The patient received intravenous immunoglobulin (IVIG) to normalize and stabilize her immunoglobulin levels and reduce the risk of recurrent infections due to her immunodeficiency with predominantly antibody defects. However, after the second administration of the medication, the patient experienced an acute skin rash and was admitted to the hospital for treatment. The treatment plan included systemic desensitizing therapy, systemic antihistamine therapy, corticosteroid therapy, and local therapy. After a course of therapy, the patient’s skin condition improved, and her overall well-being improved. However, due to the acute hypersensitivity reaction, the IVIG therapy was discontinued. The multidisciplinary team of specialists concluded that the patient had developed EM. The discussion provides an overview of EM, including its causes, clinical presentation, diagnostic tools, and therapy principles. The discussion also describes the use of human IVIG preparations in treating various immunodeficient and inflammatory diseases, highlighting the importance of monitoring patients for adverse effects. The case of this patient underscores the potential risks associated with immunoglobulin therapy and emphasizes the need for healthcare providers to remain vigilant for adverse reactions. By promptly diagnosing and treating EM, healthcare providers can minimize its impact on patients’ overall well-being.
- 16 October 2023
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 15 (1) , 182-189
Open AccessIntravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
This case report discusses immunoglobulin-induced erythema multiforme (EM), a rare and understudied condition that requires further investigation. The report presents the case of a 69-year-old woman with a history of chronic lymphocytic leukemia who developed an acute hypersensitivity reaction to intravenous gamma globulin medication. The patient received intravenous immunoglobulin (IVIG) to normalize and stabilize her immunoglobulin levels and reduce the risk of recurrent infections due to her immunodeficiency with predominantly antibody defects. However, after the second administration of the medication, the patient experienced an acute skin rash and was admitted to the hospital for treatment. The treatment plan included systemic desensitizing therapy, systemic antihistamine therapy, corticosteroid therapy, and local therapy. After a course of therapy, the patient’s skin condition improved, and her overall well-being improved. However, due to the acute hypersensitivity reaction, the IVIG therapy was discontinued. The multidisciplinary team of specialists concluded that the patient had developed EM. The discussion provides an overview of EM, including its causes, clinical presentation, diagnostic tools, and therapy principles. The discussion also describes the use of human IVIG preparations in treating various immunodeficient and inflammatory diseases, highlighting the importance of monitoring patients for adverse effects. The case of this patient underscores the potential risks associated with immunoglobulin therapy and emphasizes the need for healthcare providers to remain vigilant for adverse reactions. By promptly diagnosing and treating EM, healthcare providers can minimize its impact on patients’ overall well-being.
- 28 May 2021
- Published by Rezekne Academy of Technologies in SOCIETY. INTEGRATION. EDUCATION. Proceedings of the International Scientific Conference
- Vol. 4, 491-499
THE IMPORTANCE OF EDUCATION TO REDUCE SELF-DESTRUCTIVE NAIL HABITS
Onychophagia and onychotillomania are rarely seen in clinical practice and are considered undervalued. The study aims were to determine the prevalence of onychophagia and onychotillomania habit in the patient group with hand nail damage and control group, to determine which would be the target population to educate. Patients were interviewed about self-destructive habits. Excel and SPSS were used for data analysis. In the nail damage group, 28.6% of the respondents showed self-destructive habits and past habits – 31.4%. In the control group, the result was 22.9% and 31.4%. For 74.3% of patients the cause of nail damage was skin disease (including 61.54% of respondents with nail damage who have psoriasis), for 5.7% it was age-related nail changes, for 20% traumatic damage and for 57.14% of them it was a result of self-destructive habit. In the nail damage group both – present and past self-destructive habits are higher than in the control group, but it has no statistical significance (p=0.785). 1)The prevalence of onychophagia and onychotillomania does not differ between patients and control group. 2)General education of the population is necessary to actualize this problem, which can worsen nail changes.
- 28 May 2021
- Published by Rezekne Academy of Technologies in SOCIETY. INTEGRATION. EDUCATION. Proceedings of the International Scientific Conference
- Vol. 4, 491-499
THE IMPORTANCE OF EDUCATION TO REDUCE SELF-DESTRUCTIVE NAIL HABITS
Onychophagia and onychotillomania are rarely seen in clinical practice and are considered undervalued. The study aims were to determine the prevalence of onychophagia and onychotillomania habit in the patient group with hand nail damage and control group, to determine which would be the target population to educate. Patients were interviewed about self-destructive habits. Excel and SPSS were used for data analysis. In the nail damage group, 28.6% of the respondents showed self-destructive habits and past habits – 31.4%. In the control group, the result was 22.9% and 31.4%. For 74.3% of patients the cause of nail damage was skin disease (including 61.54% of respondents with nail damage who have psoriasis), for 5.7% it was age-related nail changes, for 20% traumatic damage and for 57.14% of them it was a result of self-destructive habit. In the nail damage group both – present and past self-destructive habits are higher than in the control group, but it has no statistical significance (p=0.785). 1)The prevalence of onychophagia and onychotillomania does not differ between patients and control group. 2)General education of the population is necessary to actualize this problem, which can worsen nail changes.
- 16 December 2020
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (1) , e14687
Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia
Hidradenitis suppurativa (HS) is a chronic, recurrent, debilitating, and frequently misdiagnosed inflammatory skin disease that often requires surgical intervention. To assess the prevalence of HS patients in surgeons’ practice and surgeons’ approach to treating HS patients, we created a self‐administered, Hurley stage‐based questionnaire that was distributed during the Latvian Association of Surgeons meeting. Of the total 60 questionnaires distributed, 56 (93%) were collected and 53 (88%) of them were considered valid. Overall, 73.6% of the surgeons confirmed having seen patients with chronic inflamed suppurative lesions in the skin folds during their practice. Median reported number of HS patients in the surgeons’ practice was 3, ranging from 0 to 30. Similarly, 73.6% of surgeons would undertake HS treatment. The proportion of surgeons undertaking treatment was higher if the surgeons had diagnosed HS by themselves but was not affected by personal knowledge of HS. Surgeons chose monotherapy for Hurley stages I, II, and III in 64.2%, 64.2%, and 62.3% of the cases, respectively. The most common therapeutic choice for monotherapy was topical antiseptics (26.4%) or topical antibiotics (20.8%) for Hurley stage I and surgery or systemic antibiotics for Hurley stage II (20.8% or 17.0%, respectively) and Hurley stage III (32.1% or 11.3%, respectively). A wide diversity of treatment approaches in specified clinical scenarios was observed, which indicates the need for local guidelines.
- 16 December 2020
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (1) , e14687
Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia
Hidradenitis suppurativa (HS) is a chronic, recurrent, debilitating, and frequently misdiagnosed inflammatory skin disease that often requires surgical intervention. To assess the prevalence of HS patients in surgeons’ practice and surgeons’ approach to treating HS patients, we created a self‐administered, Hurley stage‐based questionnaire that was distributed during the Latvian Association of Surgeons meeting. Of the total 60 questionnaires distributed, 56 (93%) were collected and 53 (88%) of them were considered valid. Overall, 73.6% of the surgeons confirmed having seen patients with chronic inflamed suppurative lesions in the skin folds during their practice. Median reported number of HS patients in the surgeons’ practice was 3, ranging from 0 to 30. Similarly, 73.6% of surgeons would undertake HS treatment. The proportion of surgeons undertaking treatment was higher if the surgeons had diagnosed HS by themselves but was not affected by personal knowledge of HS. Surgeons chose monotherapy for Hurley stages I, II, and III in 64.2%, 64.2%, and 62.3% of the cases, respectively. The most common therapeutic choice for monotherapy was topical antiseptics (26.4%) or topical antibiotics (20.8%) for Hurley stage I and surgery or systemic antibiotics for Hurley stage II (20.8% or 17.0%, respectively) and Hurley stage III (32.1% or 11.3%, respectively). A wide diversity of treatment approaches in specified clinical scenarios was observed, which indicates the need for local guidelines.
- Open Access
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Polish Journal of Pathology
- Vol. 3 (3) , 258-269
Eradication of damaged keratinocytes in cutaneous lichen planus forms demonstrated by evaluation of epidermal and follicular expression of CK15, indices of apoptosis and regulatory protein S100
The study of cytoskeleton arrangement and its contribution to survival of cell-to-cell contacts appears to be essential for understanding of numerous cellular and tissue processes. Applying CK15, S100 labeling and TUNEL reaction to cutaneous lichen planus subtypes, we found CK15 expression in the...
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Polish Journal of Pathology
- Vol. 3 (3) , 258-269
Open AccessEradication of damaged keratinocytes in cutaneous lichen planus forms demonstrated by evaluation of epidermal and follicular expression of CK15, indices of apoptosis and regulatory protein S100
The study of cytoskeleton arrangement and its contribution to survival of cell-to-cell contacts appears to be essential for understanding of numerous cellular and tissue processes. Applying CK15, S100 labeling and TUNEL reaction to cutaneous lichen planus subtypes, we found CK15 expression in the...